If you are wondering whether Amphastar Pharmaceuticals’ current share price reflects its true worth, you are not alone. This article is designed to help you assess that.
The stock last closed at US$27.74, with returns of 3.6% over the past week, 8.1% over the past month, 4.8% year to date and a 24.3% decline over the past year, alongside a 44.0% gain over five years.
Recent attention on Amphastar Pharmaceuticals has been shaped by ongoing discussions around its product portfolio and position in the pharmaceuticals and biotech space. This context helps frame how investors interpret the mix of shorter term share price moves and the longer term track record you see in the return figures.
